STERIS PLC (STE) Stock Overview
USA - NYSE:STE - IE00BFY8C754 - Common Stock
STE Key Statistics, Chart & Performance
The current stock price of STE is 240.91 USD. In the past month the price decreased by -1.82%. In the past year, price increased by 6.99%.
STE Latest News, Press Relases and Analysis
STE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.49 | 221.35B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.02 | 197.61B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.72 | 151.78B | ||
| SYK | STRYKER CORP | 29.86 | 146.70B | ||
| MDT | MEDTRONIC PLC | 17.02 | 120.74B | ||
| BDX | BECTON DICKINSON AND CO | 13.11 | 53.61B | ||
| IDXX | IDEXX LABORATORIES INC | 53.91 | 51.79B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.45 | 47.45B | ||
| RMD | RESMED INC | 27.14 | 37.83B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.81 | 35.77B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.3 | 27.82B | ||
| DXCM | DEXCOM INC | 41.55 | 27.70B |
Related stock screener links
About STE
Company Profile
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Company Info
STERIS PLC
70 Sir John Rogerson's Quay
DUBLIN D02 R296 IE
CEO: Walter M Rosebrough
Employees: 17787
Phone: 35312322000
STERIS PLC / STE FAQ
Can you describe the business of STERIS PLC?
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Can you provide the latest stock price for STERIS PLC?
The current stock price of STE is 240.91 USD. The price increased by 0.06% in the last trading session.
Does STERIS PLC pay dividends?
STERIS PLC (STE) has a dividend yield of 1.04%. The yearly dividend amount is currently 2.23.
What is the ChartMill rating of STERIS PLC stock?
STE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists STE stock?
STE stock is listed on the New York Stock Exchange, Inc. exchange.
Would investing in STERIS PLC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STE.
Can you provide the ownership details for STE stock?
You can find the ownership structure of STERIS PLC (STE) on the Ownership tab.
STE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to STE. When comparing the yearly performance of all stocks, STE turns out to be only a medium performer in the overall market: it outperformed 52.83% of all stocks.
STE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to STE. STE scores excellent on profitability, but there are some minor concerns on its financial health.
STE Financial Highlights
Over the last trailing twelve months STE reported a non-GAAP Earnings per Share(EPS) of 9.54. The EPS increased by 6.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.61% | ||
| ROA | 6.21% | ||
| ROE | 9.28% | ||
| Debt/Equity | 0 |
STE Forecast & Estimates
13 analysts have analysed STE and the average price target is 277.87 USD. This implies a price increase of 15.34% is expected in the next year compared to the current price of 240.91.
For the next year, analysts expect an EPS growth of 9.15% and a revenue growth 8.36% for STE